Search research articles
Contact Us
Filters
Showing results (531-540 of 573) with videos related to
Page
of 58
Sort By:
Nature Structural & Molecular Biology
|
October 16, 2020
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiangdong Huo, Audrey Le Bas, Reinis R Ruza, et al.
Journal of the Canadian Association of Gastroenterology
|
November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary
M Ellen Kuenzig, Joseph W Windsor, Lisa Barrett, et al.
Nature Structural & Molecular Biology
|
July 15, 2020
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiandong Huo, Audrey Le Bas, Reinis R Ruza, et al.
Nature Structural & Molecular Biology
|
February 4, 2021
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiandong Huo, Audrey Le Bas, Reinis R Ruza, et al.
BMC Medicine
|
November 7, 2024
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches)
Conall H Watson, Pierre-Stéphane Gsell, Yper Hall, et al.
Eclinicalmedicine
|
January 4, 2021
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
Pablo Tebas, ShuPing Yang, Jean D Boyer, et al.
The Lancet. Global Health
|
December 14, 2016
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study
Daouda Sissoko, Sophie Duraffour, Romy Kerber, et al.
Iscience
|
December 13, 2023
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
Helen Ratcliffe, Karen S Tiley, Stephanie Longet, et al.
The Lancet. Infectious Diseases
|
October 16, 2020
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study
Ruth Thom, Thomas Tipton, Thomas Strecker, et al.
Plos Neglected Tropical Diseases
|
May 31, 2017
Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections
Eleonora Cimini, Domenico Viola, Mar Cabeza-Cabrerizo, et al.
Page
of 58
Search research articles
Search
Showing results (531-540 of 573) with videos related to
Sort By:
Page
of 58
Nature Structural & Molecular Biology
|
October 16, 2020
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiangdong Huo, Audrey Le Bas, Reinis R Ruza, et al.
Journal of the Canadian Association of Gastroenterology
|
November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary
M Ellen Kuenzig, Joseph W Windsor, Lisa Barrett, et al.
Nature Structural & Molecular Biology
|
July 15, 2020
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiandong Huo, Audrey Le Bas, Reinis R Ruza, et al.
Nature Structural & Molecular Biology
|
February 4, 2021
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiandong Huo, Audrey Le Bas, Reinis R Ruza, et al.
BMC Medicine
|
November 7, 2024
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches)
Conall H Watson, Pierre-Stéphane Gsell, Yper Hall, et al.
Eclinicalmedicine
|
January 4, 2021
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
Pablo Tebas, ShuPing Yang, Jean D Boyer, et al.
The Lancet. Global Health
|
December 14, 2016
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study
Daouda Sissoko, Sophie Duraffour, Romy Kerber, et al.
Iscience
|
December 13, 2023
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
Helen Ratcliffe, Karen S Tiley, Stephanie Longet, et al.
The Lancet. Infectious Diseases
|
October 16, 2020
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study
Ruth Thom, Thomas Tipton, Thomas Strecker, et al.
Plos Neglected Tropical Diseases
|
May 31, 2017
Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections
Eleonora Cimini, Domenico Viola, Mar Cabeza-Cabrerizo, et al.
Page
of 58